Journal
GLYCOCONJUGATE JOURNAL
Volume 21, Issue 6, Pages 295-304Publisher
SPRINGER
DOI: 10.1023/B:GLYC.0000046272.38480.ef
Keywords
sphingolipids; glycosphingolipidoses; lysosomal storage disease; calcium; phospholipids; apoptosis; inflammation
Categories
Ask authors/readers for more resources
The glycosphingolipid lysosomal storage diseases are a group of monogenic human disorders caused by the impaired catalytic activity of enzymes responsible for glycosphingolipid catabolism. Clinical presentation of the diseases is heterogeneous, with little obvious correlation between the kind of accumulating glycosphingolipid and disease progression or pathogenesis. In this review, we discuss clinical symptoms of this group of diseases, and attempt to link disease progression and pathology with the biochemical and cellular pathways that may be potentially altered in the diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available